ProQR Therapeutics N.V. (PRQR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

Revenue TTM

0 7M 14M 21M Q1 '22: 2.5M Q2 '22: 3.2M Q3 '22: 3.1M Q4 '22: 3.6M Q1 '23: 3.1M Q2 '23: 3.4M Q3 '23: 4M Q4 '23: 6.5M Q1 '24: 10.3M Q2 '24: 15.4M Q3 '24: 17.9M Q4 '24: 18.9M Q1 '25: 19M Q2 '25: 16.5M Q3 '25: 15.5M Q4 '25: 15.9M Q2 '22 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25

Gross Profit TTM

-75M -50M -25M 0 25M 50M 75M Q1 '22: -63.1M Q2 '22: -65.5M Q3 '22: -70.5M Q4 '22: -65.9M Q1 '23: -58.2M Q2 '23: -51.1M Q3 '23: -38.6M Q4 '23: -34.9M Q1 '24: -33.7M Q2 '24: -28.6M Q3 '24: -30.1M Q4 '24: -31.1M Q1 '25: -33.9M Q2 '25: -42.5M Q3 '25: -45M Q4 '25: -43.9M Q2 '22 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q1 '21: -38M Q2 '21: -47.8M Q3 '21: -51.5M Q4 '21: -57.2M Q1 '22: -62.1M Q2 '22: -64.8M Q3 '22: -70M Q4 '22: -65.2M Q1 '23: -57.5M Q2 '23: -50.5M Q3 '23: -38.1M Q4 '23: -31.9M Q1 '24: -30.5M Q2 '24: -25.3M Q3 '24: -26.7M Q4 '24: -30.5M Q1 '25: -33.2M Q2 '25: -41.9M Q3 '25: -44.4M Q4 '25: -43.4M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Net Income TTM

-75M -50M -25M 0 25M 50M 75M Q1 '21: -43.2M Q2 '21: -54.8M Q3 '21: -56.7M Q4 '21: -61.7M Q1 '22: -63.2M Q2 '22: -60.9M Q3 '22: -69.1M Q4 '22: -64.2M Q1 '23: -58.9M Q2 '23: -53.4M Q3 '23: -35.6M Q4 '23: -27.7M Q1 '24: -26.5M Q2 '24: -21.3M Q3 '24: -23.9M Q4 '24: -27.8M Q1 '25: -30.2M Q2 '25: -39.7M Q3 '25: -42.6M Q4 '25: -42.2M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Cost of Revenue TTM

0 30M 60M 90M Q1 '21: 47.3M Q2 '21: 49.1M Q3 '21: 53.7M Q4 '21: 59.6M Q1 '22: 65.6M Q2 '22: 68.6M Q3 '22: 73.6M Q4 '22: 69.5M Q1 '23: 61.3M Q2 '23: 54.5M Q3 '23: 42.6M Q4 '23: 41.4M Q1 '24: 44M Q2 '24: 44M Q3 '24: 48M Q4 '24: 50M Q1 '25: 52.8M Q2 '25: 59M Q3 '25: 60.5M Q4 '25: 59.8M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q1 '21: -43.8M Q2 '21: -43.3M Q3 '21: -41.6M Q4 '21: -26M Q1 '22: -34.7M Q2 '22: -39.6M Q3 '22: -46.9M Q4 '22: -68.5M Q1 '23: -3.3M Q2 '23: 1.2M Q3 '23: 9M Q4 '23: 21.5M Q1 '24: -38.3M Q2 '24: -34.2M Q3 '24: -32.4M Q4 '24: -36.4M Q1 '25: -37.1M Q2 '25: -42.2M Q3 '25: -48.8M Q4 '25: -52.8M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q1 '21: -44.6M Q2 '21: -43.8M Q3 '21: -41.9M Q4 '21: -26.5M Q1 '22: -35.4M Q2 '22: -40.5M Q3 '22: -47.8M Q4 '22: -69.2M Q1 '23: -3.9M Q2 '23: 518K Q3 '23: 8.3M Q4 '23: 20.2M Q1 '24: -40.3M Q2 '24: -36.2M Q3 '24: -34.3M Q4 '24: -37.8M Q1 '25: -38M Q2 '25: -42.9M Q3 '25: -49.4M Q4 '25: -53.8M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '20: 49.9M Q2 '20: 50M Q3 '20: 50.1M Q4 '20: 50.2M Q1 '21: 50.8M Q2 '21: 66.1M Q3 '21: 68.3M Q4 '21: 71.2M Q1 '22: 71.4M Q2 '22: 71.4M Q3 '22: 71.4M Q1 '23: 80.9M Q2 '23: 80.9M Q3 '23: 81M Q1 '24: 81.6M Q2 '24: 81.7M Q3 '24: 81.7M Q1 '25: 105.3M Q2 '25: 105.3M Q3 '25: 105.3M Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q1 '21: -0.85 Q2 '21: -1.01 Q3 '21: -0.97 Q4 '21: -0.97 Q1 '22: -0.92 Q2 '22: -0.87 Q3 '22: -0.98 Q4 '22: -0.90 Q1 '23: -0.81 Q2 '23: -0.72 Q3 '23: -0.46 Q4 '23: -0.35 Q1 '24: -0.33 Q2 '24: -0.26 Q3 '24: -0.29 Q4 '24: -0.31 Q1 '25: -0.32 Q2 '25: -0.41 Q3 '25: -0.41 Q4 '25: -0.40 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.